We demonstrate targeted perturbation of neuronal activity with controlled release of neurochemicals from conducting polymer-coated microelectrodes. Polymer coating and chemical incorporation are achieved through individually addressable electrodeposition, a process that does not compromise the recording capabilities of the electrodes. Release is realized by the application of brief voltage pulses that electrochemically reduce the polymer and dissociate incorporated neurochemicals; whereby they can diffuse away and achieve locally effective concentrations. Inhibition of evoked synaptic currents in neurons within 200 μm of a 6-cyano-7-nitroquinoxaline-2,3-dione releasing electrode lasts for several seconds. Spiking activity of neurons in local circuits recorded extracellularly near the releasing electrode is silenced for a similar duration following release. This methodology is compatible with many neuromodulatory chemicals and various recording electrodes, including in vitro and implantable neural electrode arrays, thus providing an inexpensive and accessible technique capable of achieving sophisticated patterned chemical modulation of neuronal circuits.
Introduction
Fundamental brain operations including perception, memory formation and decision-making are conducted by functional groupings of neurons that form intricate circuits [1] [2] [3] . Technological advances in multielectrode array (MEA) recording now permit the study of such ensemble neuronal 6 These authors contributed equally to this paper. 7 Author to whom any correspondence should be addressed. activity both in vitro and in vivo [4, 5] .
Targeted pharmacological manipulation combined with recording techniques using MEAs are often desired for investigating the dynamics of functional neural circuits, as well as the underlying cellular mechanisms. Methodologies for focal perturbation include optogenetics [6] , caged compounds [7] , pressure injection [8] , microiontophoresis [8, 9] and microfluidics [10] . Each technique has unique advantages and limitations regarding ease of use, tissue damage and spatiotemporal control. Recent efforts to integrate microelectrodes with fluidic channels through nanofabrication eliminate the requirement of extra positioning devices and improve the spatial resolution of local delivery [11] [12] [13] . However, the addition of channels, pumps and valves for active delivery control complicates device fabrication, and can lead to lower yield, higher cost and higher failure rate [14] . Furthermore, the size of the device is increased, making it more likely to cause insertion injury and host tissue reaction for in vivo applications [15] .
Here, we describe an additional technique for local release based on the redox properties of conducting polymers. Conducting polymers can be selectively grown on individual microelectrodes where they require ionic dopants in order to conduct electric currents [16] . Upon electrical stimulation they can repeatedly release small quantities of doping molecules into solution [17] [18] [19] [20] [21] . When applied to MEAs, this technique allows for the controlled release of preincorporated neurochemicals from any given electrode or multiple electrodes simultaneously while neuronal activities are being recorded. Based on this principle, we have developed a new system of individually addressable polypyrrole (PPy) films capable of targeted, real-time delivery of small amounts of charged neurochemicals. The system can be easily integrated into commercially available MEAs without complex microfabrication. The method is inexpensive and easy to use. In addition, its small size is advantageous for potential in vivo applications where tissue damage can be minimized because extra devices are unnecessary, and release is mediated through ionic diffusion with minimal volume displacement [21, 22] .
In this communication, we choose 2-amino-5-phosphonopentanoate (AP5) and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), inhibitors of NMDA and AMPA-type glutamate receptors, respectively [23] . Both chemicals retained their inhibitory bioactivity after release from the conducting polymer PPy. Real-time chemical release from prefabricated MEAs is visualized through the incorporation of fluorescein and its release. PPy-CNQX and PPy-control films are synthesized on selected electrodes of MEAs and the recording capabilities of these polymer-coated electrodes are shown to be comparable to standard platinum black electrodes. Synaptic currents recorded by patch clamp of individual neurons grown on modified MEAs show transient inhibition by brief CNQX release from drug-loaded electrodes in a diffusion-dependent fashion. Finally, spiking activity of local networks grown on the recording MEAs is selectively and repeatedly inhibited by CNQX release from nearby electrodes. These results demonstrate the effectiveness of this simple and easy-to-use system.
Methods

PPy synthesis and release
Custom-made gold-coated plastic coverslips (Fisher) were used as macro-electrodes for the electrochemical deposition of polymer and the release of neurochemicals. In order to ensure constant current density and provide suitable sized surfaces to fit in tissue culture wells, the coverslips were cut to uniform dimensions of 7 × 22 mm. The coverslips were cleaned with 8 N HNO 3 for 30 min followed by two washes in deionized H 2 O and stored in ethanol until gold deposition. To create a conductive surface for electrochemical deposition, the cut, cleaned coverslips were sputter coated with a layer of gold using a Cressington Sputter Coater (Cressington Scientific Instruments, Inc.) with thickness control. The thickness of the gold layer was approximately 40 nm. The coated coverslips were stored in a dessicator until used.
To prepare individual MED64 arrays (Panasonic) for polymer deposition and cell culture, they were exposed to pure oxygen plasma for 8 s and then stored in sterile PBS until electrochemical deposition. Pyrrole (Sigma) was vacuum distilled and stored frozen. Dopants for this study are CNQX sodium salt (Sigma), AP5 (Sigma), fluorescein sodium salt (Sigma) and the ions found in PBS (Sigma). Films were synthesized directly on the electrodes of the MED array (2.5 × 10 −5 cm 2 ) or on custom-made gold macro-electrodes. The monomer solutions consisted of 0.5 M Py and either 7.5 mg ml −1 CNQX, 10 mM Fluorescein, 10 mg ml
AP5, or the ions contained in PBS. A platinum foil counter electrode and an Ag/AgCl reference electrode were used for the electropolymerization. For PPy-CNQX and PPyfluorescein coatings, 800 mV was applied for 100 s. For PPy-PBS coatings, 700 mV was applied for 20 s. To determine appropriate release parameters, the duration of the release pulse was varied from 200 ms to 4 s. The magnitude of the voltage was varied from 1.0 to 5.0 V. The Conductor software (MED64, Panasonic) was programmed to control all other hardware including a 16 bit EM-CCD camera (Cascade 512B, Roper Scientific) and an illumination source (Lambda DG4, Sutter Instruments). The camera attached to a PC took images at 10 Hz and the exposure time was set to 100 ms.
Neuronal culture and electrophysiology
PPy coating synthesis was done on the day prior to cell culture. Under laminar flow, the chambers were washed once with ultrapure H 2 O, and then UV exposed for 30 min for sterilization. Following sterilization, the chambers were washed five times with ultrapure H 2 O to remove any remaining monomer solution. The surfaces of the chips were then treated according to a previously described protocol [24] . Briefly, 0.05% polyethyleneimine (PEI, Sigma P3143) was incubated at room temperature for 1 h followed by four washes with ultrapure H 2 O. A solution containing 20 μg ml −1 of laminin (Sigma L2020) in DMEM (Invitrogen 11960) was added after the final wash and incubated overnight. On the day of culture the MEAs were removed from the incubator and washed five times with ultrapure H 2 O. Following the final wash, all of the solution was removed from the chamber and the surface was allowed to dry until cells were plated.
Low-density cultures of dissociated embryonic rat hippocampal neurons were prepared as described previously [25] .
Hippocampi were removed from embryonic day 18-20 (E18-20) rats and treated with trypsin for 15 min at 37
• C, followed by washing and gentle trituration. The 2-3 μl drops of dissociated cells were plated at a density of 200-400 cells mm −2 on PEI-and laminin-treated MED64 arrays. The plating medium was DMEM w/o HEPES (BioWhittaker) supplemented with 2% heat-inactivated fetal bovine serum (Hyclone), 8% bovine calf serum, 10% Ham's F12 with glutamine (BioWhittaker), 25 mM HEPES buffer, B27 and 50 U ml −1 penicillin-streptomycin (Sigma). Twentyfour hours after plating, the culture medium was changed to the above medium containing 20 mM KCl. Cytosine arabinoside (Sigma) was added to the culture dish (final concentration, 5 μM) around 7-10 DIV to prevent overgrowth of glial cells. Both glial and neuronal cell types are present under these culture conditions. Cells were used for electrophysiological recordings after 8-14 days in culture. For high-density cultures (1000-1200 cells mm −2 ) the protocol for culture was derived from [26] . As a source of cortical neurons, E18 cortex pairs were purchased from Brainbits LLc., and the supplied dissociation protocol was followed.
For perforated-patch recordings, the micropipettes were made from borosilicate glass capillaries (Kimax), with a resistance in the range of 2-4 M . The pipettes were tip filled with internal solution and then backfilled with internal solution containing amphotericin B (Sigma). The pipette solution contained 136.5 mM potassium gluconate, 17.5 mM KCl, 9 mM NaCl, 1 mM MgCl2, 10 mM Hepes, 0.2 mM EGTA and 200 μg ml −1 amphotericin B (pH 7.3). The external bath solution was a Hepes-buffered saline (HBS) containing 150 mM NaCl, 3 mM KCl, 3 mM CaCl 2 , 2 mM MgCl 2 , 10 mM Hepes and 5 mM glucose (pH 7.3). The bath was perfused with fresh recording medium at a slow rate throughout the recording, and all experiments were performed at room temperature. The neurons were visualized by phase-contrast microscopy with an inverted microscope (Leica DMIRB). Recordings were performed with one or two patch clamp amplifiers (Axopatch 200B, Axon Instruments). Signals filtered at 2 kHz were acquired at a sampling rate of 11.1 kHz by using a 16 bit digitizing board (DigiData 3200, Axon Instruments) and processed with the pCLAMP software (Axon Instruments). For assaying network correctivity, each electrode was stimulated at 1 V for 100 μs, and the responses from the neurons were recorded. Extracellular recordings were simultaneously collected from an array of 64 microelectrodes (MED64, Panasonic). Signals were band-pass filtered between 100 Hz and 10 kHz, sampled at 20 kHz and stored for offline analysis. Spike waveforms were isolated and sorted using the Offline Sorter (Plexon Inc.).
Data analysis
The signal to noise ratio (SNR) for an electrode was computed using SNR = 20 * log 10 rms(wavef orm) rms(rawdata) 2 , where waveform is the peak-to-peak magnitude of the extracted waveforms and rawdata is the data segment from which the spikes were extracted. A t statistic was used to compare the log of SNRs for two groups of electrodes, platinum and conducting polymer.
A point source diffusion model used to numerically simulate the amount of release is written as c(
, where c is the concentration as a function of distance (x) and time (t), Q is the amount of substance released per unit area (measured to be 12.5 ng cm −2 ) and D is the diffusion constant in water (2 × 10 −5 cm 2 s −1 ) [27] . Standard statistical analysis was performed in SPSS. The two-tailed t-test (α = .05) was used to compare two means. ANOVA was used for tests including multiple comparisons (α = 0.05) and Bonferroni correction was used to identify pair-wise differences post hoc. To estimate the time-varying firing rate of individual neurons recorded extracellularly, a peri-stimulus time histogram (PSTH) was computed for each neuron. The spike times were counted across trials in 5 ms bins. To correct for sampling errors, the resulting histogram was smoothed using Bayesian adaptive regression splines (BARS) [28] .
Results
The fundamental concept of drug incorporation and controlled release from conducting polymer films is illustrated in figures 1(a) and (b), respectively.
PPy can be electrochemically polymerized and deposited directly on the anode. A charged neural chemical A − can be incorporated into PPy as a dopant during electrochemical synthesis and associated with the positive charges that accumulate on the backbone of the polymer. Upon electrical stimulation, PPy undergoes a reversible redox reaction whereby discharging and recharging of the backbone is accompanied by the movement of hydrated ions (figure 1(b) and supplementary figure 1, available at stacks.iop.org/JNE/8/044001/mmedia). In preliminary experiments, CNQX and AP5 released from custom-made, large (0.7 cm 2 ) electrodes blocked the reverberatory activity of cultured neuronal networks when added to the bath solution separately, indicating that both chemicals retained their native bioactivity (supplementary figure 1, available at stacks.iop.org/JNE/8/044001/mmedia).
Electrochemical release of CNQX and fluorescein
To estimate the amount of CNQX released from PPy films through voltage stimulation, custom-made gold-coated macro-electrodes (0.7 cm 2 ) were used as a model release source. The potential was swept across the range −1 V to 0.8 V 20 times and the UV absorption of the resulting solution was measured at 254 nm.
Using a standard curve derived from CNQX solutions of known concentration measured at 254 nm (supplementary figure 2, available at stacks.iop.org/JNE/8/044001/mmedia), this procedure resulted in 12.5 ± 1 ng cm −2 of CNQX per stimulation (n = 2 coverslips tested). By scaling down for size, the estimated amount of release from the MEA electrode (2500 μm 2 ) is slightly larger than 300 fg per release. To visualize the dynamics of controlled chemical release from microelectrodes and measure the effect of different voltage stimulations, PPy films doped with fluorescent dye fluorescein were synthesized on MEA electrodes. Fluorescein has a similar molecular weight to CNQX and both molecules carry two negative charges. Unlike CNQX, the release of fluorescein upon delivery of voltage pulses can easily be detected using fluorescent microscopy (figure 1(c) and supplementary movie, available at stacks.iop.org/JNE/8/044001/mmedia). To reveal the relationship between the magnitude of voltage pulses and the amount of fluorescein release, average fluorescence intensity was calculated in a 0.063 mm 2 region of interest (ROI) surrounding the release electrode, and individual timeseries were normalized by subtracting the mean intensity of the ROI in the first 10 frames (prior to fluorescein release) from each subsequent frame of the series. Higher stimulus strength leads to more fluorescein release ( figure 1(d) ) indicating that this is a true electrically controlled release. Across 11 electrodes, the magnitude necessary to detect release ranged from −1.7 V to −2.3 V. To test whether the high magnitude drug-releasing stimulus damaged the electrodes, impedance spectroscopy was measured before and after release. No apparent change in the physiologically relevant 1 kHz impedance was measured after applying the release stimulus to either a polymer-coated or pt-black electrode (supplementary figure 3, available at stacks.iop.org/JNE/8/044001/mmedia).
Due to the scale of the microelectrodes, direct measurement of CNQX micro-release was not performed. The measurements obtained from the macro-release experiments were used in a numerical simulation based on Fick's diffusion model to estimate CNQX concentration as a function of distance and time from release in a microelectrode array (see the Methods section). The simulated concentration as a function of distance is plotted for seven different time points and shows that the CNQX release measured from the macroelectrodes would produce physiologically relevant CNQX concentrations [25] in a temporally restricted fashion in the MEA (figure 2).
Electrophysiological effect of local CNQX release on single neurons
CNQX competitively blocks glutamate binding to AMPAand Kainate-type receptors [23] . PPy-CNQX films were grown directly on the pt-black surface of the MEA electrodes. The films did not have a negative impact on the ability of the electrodes to record action potentials as both the 1 kHz impedance ( figure 3(a) ) and the SNR ( figure 3(b) ) were similar on coated and uncoated electrodes. To directly monitor the effect of CNQX release from electrodes, patchclamp recordings were made on individual neurons at various locations in the MEA dish (supplementary figure 4(a) , available at stacks.iop.org/JNE/8/044001/mmedia). A brief neural stimulation (1 V, 100 μs) at one of the 64 extracellular electrodes could potentially activate one or more nearby neurons and, if the activated neurons were directly or indirectly connected to a patched neuron, could elicit monoor polysynaptic currents (supplementary figure 4(b) , available at stacks.iop.org/JNE/8/044001/mmedia). These responses provided a baseline from which inhibition could be observed. To examine the temporal profile of the inhibitory effects of released CNQX, we used short trains of neural stimulations from an electrode found to elicit a reliable monosynaptic current trace. Three trial types were performed: baseline control (no release stimulus), stimulus control (where the release stimulus was applied to an electrode coated with PPy films synthesized from blank PBS), and CNQX release trials. The release stimuli were cosine waveform with an amplitude of −2.5 V for 200 ms. Immediately after CNQX release, a reduction in the magnitude of excitatory post-synaptic current (EPSC) was observed; this lasted for at least 7.5 s ( figure 4(a) ), followed by full recovery seen on the pre-release EPSC during the next trial, approximately 2 min later ( figure 4(b) ). Meanwhile, no inhibition occurred during the stimulus control trials (figures 4(a) and (c)).
To investigate the spatial specificity of the technique, patch recordings were made on 18 different neurons at varying distances from 25 PPy electrodes (21 containing CNQX and four without CNQX as the stimulus control) in six different MEAs. The distance between the patched neuron and the release source had a significant effect on inhibition; reliable inhibition was obtained when the electrode was within 250 μm of the cell ( figure 4(d) ). Finally, the inhibition was examined as a function of the estimated concentration at the distance between the cell and the release electrode at the time measured for different neurons. Figure 4(e) illustrates that the percentage of inhibition is predicted by the estimated concentration. The predicted values are in general agreement with known concentration effects of CNQX [25] , suggesting that the amount of CNQX measured during macro-release is a good indicator of the amounts released in real-time in the dish.
Local network effects of CNQX release
Finally, we examined the effects of the repeated release of CNQX on local network activity recorded by the PPy-CNQX modified multi-electrode array. In such networks, bursting activity could be repeatedly evoked by brief electrical stimuli delivered through the substrate electrodes, just as in normal MEAs [29] . Repeated release (five times) of CNQX from substrate electrodes could reliably attenuate the number of spikes, comprising an evoked response on nearby electrodes. c.
CNQX a.
CNQX release A similar distance and time effect observed with individual neurons after release of CNQX is discernable in the firing rate histogram from neurons monitored by extracellular electrodes (figure 5). In another experiment, when a weaker stimulus was applied (1.5 V for 1 s), CNQX release reversibly blocked the spontaneous neuronal firing recorded on the same electrode without blocking activity recorded on a nearby electrode 150 μm away. The smaller effective radius compared to the effect seen above could be due to the fact that a smaller magnitude stimulus was applied, and it also highlights the large space to optimize the stimulation parameters according to the application requirements. This effect was repeated on multiple releases from the same electrode (supplementary figures 5(a) and (b), available at stacks.iop.org/JNE/8/044001/mmedia).
Discussion
A deeper understanding of the brain function will require the ability to monitor the electrical activity of many neurons simultaneously, and the ability to introduce systematic perturbations in a highly controlled fashion. The method presented here builds upon commonly used technologies in a unique manner that enables the customization of the controlled release of a small amount of neural chemicals with high spatial and temporal precision. The decision of when and from what electrode to release the agents can be made in real-time and informed by the activity being recorded, and it is entirely possible to close the loop between recording and release so that agents can be disseminated in response to particular dynamic patterns. The results presented demonstrate the effectiveness of conducting-polymer-based neurochemical release.
Current state-of-the-art focal neurochemical delivery methods include picospritzer and iontophoresis, both of which face the risk of drug leakage due to diffusion, and challenges when multiple neurochemicals and tens and hundreds of precise delivery sites are needed. Microelectrodes with microfluidic channels can achieve high-density arrays but require complicated fabrication and control schemes. Our electrode coating technology has a much simpler and inexpensive fabrication scheme. Such coating adds very little volume to the size of the device (a few or sub-micron thickness), yet the extremely dense packing of the drug in the polymer film (on the order of g cm −3 ) allows much more of the drug to be loaded in the film than in an internal reservoir or channel of the same volume (at the level of mg ml −1 , determined by the solubility of the drug). For a fully implantable system without external reservoir, this packing density makes the technology advantageous to an internal reservoir or channel. Therefore, the coating technology most efficiently minimized the size addition. Furthermore, drug release from channels is associated with the injection of a volume of fluid, which could mechanically disturb nearby neurons. In contrast, the drug comes out of the polymer film in the form of hydrated ions, thus minimizing the potential mechanical side effects.
Several challenges exist in moving this technology forward. First, the amount of molecules that can be released is limited without an external reservoir. In the research performed here, the number of releases attempted was less than 10 and found to be variable from electrode to electrode. Our lab has begun to explore means to increase the drug load and release efficiency by creating a nanostructured polymer film. Already, nanostructured PPy films have been shown to have a 10-fold increase in drug release over conventional PPy films [30] . Second, the amount released per-pulse varied considerably from one electrode to the next. One possible source of this variability is that during synthesis, voltage control was used. This would result in different amounts of charge and different amounts of polymer and dopant applied to each electrode. In future experiments current control will be used to synthesize the electrodes. A similar problem could be occurring at the time of release. The release signal was voltage controlled, which could result in a variable amount of current flow depending on the impedance of the system. Finally, in the current study the magnitude of the release voltage was high. Although this did not cause detectable neuronal damage in our short-term in vitro experiments, it would be undesirable in future animal models. The ongoing research optimizing the polymer synthesis conditions and drug-releasing stimuli should improve this aspect by lowering the impedance of the films.
Conducting polymer films have been grown on the electrodes of implantable neural electrode arrays and offer superior electrical properties and biocompatibility compared to metal electrodes [31, 32] . They have been demonstrated to survive insertion and withdrawal from the brain [32] .
Furthermore, the electrochemically-controlled release is not limited to PPy or the agents CNQX, AP5 and fluorescein. Other types of electroactive conductive polymers, such as poly(3,4-ethylenedioxythiphene) (PEDOT), can also facilitate release [33] . More importantly, the system is capable of releasing many kinds of charged molecules. Previous research has shown that dexamethasone [20] , dopamine [19] , glutamate [21] , biotin [34] , salicate, naproxen and tosylate [35] and ATP [36] can be incorporated and released from conducting polymer films. Better characterization of the number of times the release can be achieved and a reduction in the release variability would permit the application of this technology to short-term in vivo studies where small numbers of transient local releases are needed. As work on loading capacity progresses more long-term applications can be explored.
